- Crowds Wire LTD is Launching the Marketing Agency New Site
- Wohler releases iAM-AUDIO-8 with AoIP options
- Columbia: 3100 Block of Creasy Springs Road
Ms. Norwalk previously served on the Board of Magellan Health, which Centene recently acquired. She is an experienced director and throughout her accomplished career has served on boards across a wide spectrum of healthcare corporations and biotechnology companies, including NuVasive, Endologix, Providence Services Corporation, Neurocrine Biosciences and Arvinas.
"Leslie's extensive leadership and experience in the Government Healthcare and Biotech industries brings invaluable perspective to our Board as we continue to expand our efforts to bring on trusted advisors to help us deliver on the goals in our Value Creation Plan," said Michael Neidorff, Centene's Chairman and Chief Executive Officer. "She brings a fresh perspective that will help us maintain our mission while expanding our service of providing accessible, high-quality healthcare to our most vulnerable populations."
Ms. Norwalk currently serves as Strategic Counsel to Epstein Becker Green, P.C., a law firm specialized in healthcare and life science industries. She also serves as an advisor to three private equity firms in healthcare policy and regulatory matters.
Ms. Norwalk began her career in the public sector, serving as the Administrator for the Centers for Medicare & Medicaid Services (CMS) under the Bush Administration. She later went on to serve as the Deputy, and later, Acting Administrator for the agency, as well as their Counselor and Policy Advisor.
"It is a pleasure to join Centene's Board of Directors during such an impactful time of change and growth for the company and healthcare industry as a whole. I'm honored to continue expanding the opportunities to provide top-quality healthcare in the communities that need it most, and support Centene in its goals of transforming the health of the communities it serves," said Norwalk. "This is the core service of managed care, and I look forward to bringing a fresh perspective and new value to this vital mission of creating better health outcomes for our community."
About Centene Corporation
Centene Corporation, a Fortune 25 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
More on Missouriar
- City of Columbia to open temporary overnight warming center at Wabash Bus Station Jan. 28
- Self-Care Routine Cards, LLC Website Launch
- QM Power Fortifies Partnership with University of North Carolina at Charlotte, Expands U.S. Presence
- Mr. Ismail Sirdah – A Man Of Intelligence And Patience
- Caleres Earns Top Score in Human Rights Campaign Foundation's 2022 Corporate Equality Index
All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, growth strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our acquisition of Magellan Health (the Magellan Acquisition), our completed acquisition of WellCare Health Plans, Inc. (WellCare and such acquisition, the WellCare Acquisition), other recent and future acquisitions, investments, and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: the impact of COVID-19 on global markets, economic conditions, the healthcare industry and our results of operations and the response by governments and other third parties; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; uncertainty as to the expected financial performance of the combined company following completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; the inability to retain key personnel; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.
More on Missouriar
- Kansas: ReBuild KC - Neighborhood Grants opens door to numerous neighborhood improvements
- Kaplan Morrell Attorneys at Law Announces New Partner
- Cinema St. Louis to Receive 100K Grant from NEA as part of American Rescue Plan
- Daniel Renner Joins Affinity Law Group, LLC
- Culinary And Cannabis Presents The CannaSpa Celebrity Gifting Lounge In Honor of Super Bowl LVI
SOURCE Centene Corporation
Filed Under: Business
Latest on Missouriar
- Columbia: Changes to COVID-19 data reporting, Information Hub
- Columbia: Lane restrictions and sidewalk closures on Worley Street to continue through February
- Sababa returns to Washington University on September 18
- ATXI receives final approval to construct the Limestone Ridge Project in southeast Missouri
- Neptuno USA, Corp Completes NAAP© Asset Management Program Implementation and 3D Site Virtualization of Vertical Portfolio of Missouri Based Gateway Towers, a Subsidiary of Chariton Valley
- Interested parties meeting scheduled regarding reconstruction of Taxiway A at Columbia Regional Airport
- Right now Unique Chrysler Jeep Dodge Ram has the largest volume of inventory in the Burlington area!
- SafuCoin (SAFUCOIN) announces it will provide a critical missing part of the infrastructure for the crypto economy – a 'trust layer'
- New hire power hitters bring additional strategic depth to help USAM's clients
- CyberSecurity Malaysia, EclecticIQ, and Syntx Sign MOU to Build Cyber Threat Intelligence Capabilities in the Region
- Springfield: Missing Person: Joseph D. Sparks
- PEABODY TO ANNOUNCE RESULTS FOR THE QUARTER ENDED DECEMBER 31, 2021
- Springfield Police Investigate Fatality Crash
- Springfield: Virtual media briefing at 10:30 am Wednesday
- CorEnergy Announces Tax Characterization of 2021 Distributions
- Commercial Collection Bureau Partners with Leadferno for B2B Text Messaging and More
- 11Sight Welcomes Jason Carver as Vice President of Product Management
- Purina Announces 2022 Pet Care Innovation Prize Winners
- Missouri Confluence Waterkeeper Announces Multi-Year Grant to Fund Clean Water Initiative in STL
- Emerson's Sensi™ Touch Smart Thermostat Wins AHRI 2021 Integrated Home Competition